The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Status unconfirmed · Phase 4

Conditions studied: Osteoporosis

In brief

This is a three-year study to evaluate the effect of sequential therapy of Forteo (teriparatide) and denosumab on bone density at the spine, hip, leg and forearm.

Key facts

Study ID
NCT02130973
Run by
Health Research, Inc.
People needed
60
Starts
2013-08-01
Expected to finish
2018-08-01
Last updated by the study team
2017-08-31

Who can join

Age: 45 and older. Sex: female. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.